Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Food Effect Study on Pharmacodynamic and Bioavailability of Clopidogrel 300/75 mg in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Saxagliptin Triple Oral Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Pharmacology Study of BMS-866949
- Status
- TERMINATED
- Phase
- PHASE1
Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Ipilimumab + Temozolomide in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of BMS-823778 in Subjects With Hypercholesterolemia
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of BMS-823778 in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment
- Status
- TERMINATED
- Phase
- PHASE3
Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications
- Status
- COMPLETED
- Phase
- PHASE4
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
- Status
- COMPLETED
- Phase
- PHASE4
Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV)
- Status
- COMPLETED
- Phase
- PHASE3
Neo-Adjuvant Study in Triple Negative Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Dose-Defining Study of CXL-1020 in Patients With Systolic Heart Failure
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Abatacept in Sweden
- Status
- COMPLETED
- Phase
- N/A
Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma
- Status
- TERMINATED
- Phase
- PHASE2